Financials

Discussions Technicals Seasonals

007570 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to ILYANG PHARMACEUTICAL operating, investing, and financing activities

007570 free cash flow for Q2 24 is -1.05 B KRW. For 2023, 007570 free cash flow was 13.29 B KRW and operating cash flow was 19.38 B KRW.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: KRW

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—